A detailed history of Bank Of Montreal transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 31,176 shares of ALNY stock, worth $8.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,176
Previous 102,508 69.59%
Holding current value
$8.49 Million
Previous $15.3 Million 50.55%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$143.31 - $247.0 $10.2 Million - $17.6 Million
-71,332 Reduced 69.59%
31,176 $7.58 Million
Q1 2024

May 13, 2024

BUY
$146.51 - $198.2 $9.16 Million - $12.4 Million
62,543 Added 156.49%
102,508 $15.3 Million
Q4 2023

Feb 08, 2024

SELL
$151.41 - $196.57 $1.25 Million - $1.62 Million
-8,238 Reduced 17.09%
39,965 $7.65 Million
Q3 2023

Nov 01, 2023

SELL
$170.77 - $211.65 $1.93 Million - $2.39 Million
-11,301 Reduced 18.99%
48,203 $8.54 Million
Q2 2023

Aug 02, 2023

BUY
$185.01 - $212.05 $6.56 Million - $7.51 Million
35,436 Added 147.23%
59,504 $11.3 Million
Q1 2023

Jun 13, 2024

SELL
$182.66 - $235.53 $8.18 Million - $10.5 Million
-44,780 Reduced 43.68%
57,728 $11.6 Million
Q4 2022

Feb 01, 2023

SELL
$185.53 - $241.31 $6.32 Million - $8.22 Million
-34,081 Reduced 58.61%
24,068 $5.72 Million
Q3 2022

Nov 10, 2022

SELL
$138.54 - $232.0 $2.62 Million - $4.39 Million
-18,932 Reduced 24.56%
58,149 $12.3 Million
Q2 2022

Aug 11, 2022

BUY
$120.42 - $169.29 $400,998 - $563,735
3,330 Added 4.52%
77,081 $11.2 Million
Q1 2022

May 12, 2022

BUY
$127.18 - $173.91 $4.36 Million - $5.96 Million
34,267 Added 86.79%
73,751 $12.4 Million
Q4 2021

Feb 11, 2022

SELL
$159.56 - $209.29 $2.21 Million - $2.9 Million
-13,857 Reduced 25.98%
39,484 $6.85 Million
Q3 2021

Nov 12, 2021

BUY
$169.75 - $207.73 $1.8 Million - $2.2 Million
10,590 Added 24.77%
53,341 $9.52 Million
Q2 2021

Aug 12, 2021

BUY
$128.63 - $176.89 $5.5 Million - $7.56 Million
42,751 New
42,751 $7.11 Million

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $33.5B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.